Identification of congenital stationary night blindness in dogs

Details Identification of congenital stationary night blindness in dogs Identification of congenital stationary night blindness in dogs

2000-08-24

2002-08-06

Priebe, Scott D. (Department: 1633)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S004000, C536S023500, C536S023100, C536S024300, C536S024310

Reexamination Certificate

active

06428958

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to the identification of the RPE65 gene in dogs, identification of a mutation in the RPE65 gene in the briard breed of dogs, a method for identifying dogs that are genetically normal, are carriers of, or are affected with congenital stationary night blindness by detecting the presence of the mutation, and a method of selecting dogs for breeding.
BACKGROUND OF THE INVENTION
The briard dog is affected with a recessively inherited retinal disorder characterized by congenital night blindness with various degrees of visual impairment under photopic illumination. Vision in affected dogs ranges from normal day vision to profound day blindness (Narfström et al., “Hereditary Retinal Dystrophy In The Briard Dog: Clinical And Hereditary Characteristics,”
Veterinary & Comparative Ophthalmology,
4:85-92 (1994)). The disease was initially described in Swedish dogs as a stationary disorder analogous to human congenital stationary night blindness (CSNB; Narfström et al., “Hereditary Retinal Dystrophy In The Briard Dog: Clinical And Hereditary Characteristics,”
Veterinary & Comparative Ophthalmology,
4:85-92 (1994)). More recently, the disease has been described as having a progressive component, and has been termed hereditary retinal dystrophy (Wrigstad et al., “Slowly Progressive Changes Of The Retina And Retinal Pigments Epithelium In Briard Dogs With Hereditary Retinal Dystrophy. A Morphologic Study,”
Doc. Ophthalmol.,
87:337-354 (1994); Wrigstad, “Hereditary Dystrophy Of The Retina And The Retinal Pigment Epithelium In A Strain Of Briard Dogs: A Clinical, Morphologic And Electroretinographic Study,” Linköping University Medical Dissertation #423 (1994)). Along with the visual impairment, affected dogs have an abnormal electroretinogram (ERG); in general, the recorded responses are normal in waveform, but show a marked diminution of response amplitudes, similar to a “Riggs type” ERG in man. The ERG recorded under DC conditions shows complete absence of the a-, b-, and c-waves, with the latter waveform being replaced by a very slow negative potential which develops when the stimulus intensity is greater than 3 log units above the normal b-wave threshold. The abnormalities in the a- and b-waves can be interpreted as representing a delay in rod phototransduction (Nilsson et al., “Changes In The DC Electroretinogram In Briard Dogs With Hereditary Congenital Night Blindness And Partial Day Blindness,”
Exp. Eye Res.,
54:291-296 (1992)). A similar disease is also recognized in other countries, e.g. France, Canada, and the United States. In the United States, the disease is termed congenital stationary nightblindness, and csnb has been designated as the gene symbol for the disease locus. Apart from the above studies in Swedish briard dogs, no other systematic investigation of the disease has been reported, nor has there been definitive proof that csnb and retinal dystrophy represent the same disorder.
The present invention is directed to overcoming the above-noted deficiencies in the prior art.
SUMMARY OF THE INVENTION
The present invention relates to an isolated nucleic acid molecule encoding canine RPE65.
The present invention also relates to an isolated nucleic acid molecule encoding canine RPE65 having a mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness.
The present invention also relates to a method for identifying dogs which are genetically normal, are carriers of, or are affected with congenital stationary night blindness, said method including obtaining a biological sample from a dog and testing the biological sample for a gene encoding canine RPE65 having a nucleic acid mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness.
Another aspect of the present invention is a method for selecting dogs for breeding which includes obtaining a biological sample from a dog, testing the biological sample for a gene encoding canine RPE65 having a nucleic acid mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness, and eliminating dogs with the mutation from a breeding stock or breeding the dogs with the mutation with genetically normal dogs.
Yet another aspect of the present invention is an isolated nucleic acid molecule including a DNA molecule having the nucleotide sequence selected from the group consisting of SEQ. ID. No. 4, SEQ. ID. No. 5, SEQ. ID. No. 6, SEQ. ID. No. 7, and SEQ. ID. No. 8.
The present invention has enabled a DNA-based diagnostic test for congenital stationary night blindness to be developed, and, therefore, animals suitable for breeding can be identified. In particular, identifying carriers for congenital stationary night blindness through the identification of the AAGA deletion mutation at nucleotides 487-490 in a gene encoding canine RPE65 allows a breeder to eliminate the carriers from the breeding stock or breed carriers with genetically normal dogs.


REFERENCES:
patent: 5705380 (1998-01-01), North et al.
Aguirre et al., “Congenital Stationary Night Blindness in the Dog: Common Mutation in the RPE65 Gene Indicates Founder Effect,”Molecular Vision4:23-29 (1998).
Veske et al., “Retinal Dystrophy of Swedish Briard/Briard-Beagle Dogs is Due to a 4-bp Deletion in RPE65,”Genomics57:57-61 (1999).
Wrigstad et al., “Ultrastructural Changes of the Retina and the Retinal Pigment Epithelium in Briard Dogs with Hereditary Congenital Night Blindness and Partial Day Blindness,”Experimental Eye Research55:805-808 (1992).
Veske et al., “Isolation of Canine Retinal Arrestin cDNA and Exclusion of Three Candidate Genes for Swedish Briard Retinal Dystrophy,”Current Eye Research16:270-274 (1997).
Veske et al., “Organization of the canine Gene Encoding the E Isoform of Retinal Guanylate Cyclase (cGC-E) and Exclusion of its Involvement in the Inherited Retinal Dystrophy of the Swedish Briard and Briard-Beagel Dogs,”Biochimica et Biophysica Acta1372:69-77 (1998).
Ray et al., “Strategies for Identification of Mutations Causing Hereditary Retinal Diseases in Dogs: Evaluation of Opsin as a Candidate Gene,”The Journal of Heredity,90:133-137 (1999).
Petersen-Jones, “Animal Models of Human Retinal Dystrophies,”Eye12:566-570 (1998).
Stades, “Hereditary Features of Progressive Retinal Atrophy (PRA) and its Consequences in Dog-Breeding,”tijdschrift voor diergeneeskunde107:29-32 (1982).
Wolf et al., “Rod-Cone Dysplasia in the Collie,”Journal of the American Veterinary Medical Association173:1331-1333 (1978).
O Toole et al., “Generalized Progressive Retinal Atrophy in Two Akita Dogs,”Vet. Pathol.21:457-462 (1984).
Bjerkás et al., “Progressive Retinal Atrophy in the Tibetan Spaniel in Norway and Sweden,”Veterinary Record134:377-379 (1994).
Acland et al., “XLPRA: A Canine Retinal Degeneration Inherited as an X-Linked Trait,”American Journal of Medical Genetics52:27-33 (1994).
Kylmä et al., “Cloning and Analysis of the cDNA Encoding the Rod G-Protein Transducin &agr;, &bgr;1 and &ggr;1 Subunits From the Canine Retina,”Gene193:1-4 (1997).
Acland et al., “Canine familiaris Retinal Pigment Epithelium-Specific Protein RPE65 (RPE65) nRNA,” Genbank Accession Number AF084537 (1998).
Veske, “Canis Familiaris mRNA for Retinal Pigment Epithelium Abundant Protein,” Genbank Direct Submission. Accession Number Y16567 (1998).
Nicoletti et al., “Molecular Characterization of the Human Gene Encoding an Abundant 61 kDa Protein Specific to the Retinal Pigment Epithelium,”Human Molecular Genetics4(4):641-649 (1995).
Han et al., “Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6),”The Journal of Biological Chemistry271(6):2886-2891 (1996).
Ronai et al., “Identification of an ETS-Like 30 kDa Protein that is Expressed in Mammary Tumors Induced by Anti-Benzol(C)phenantrene-3,4-diol-1,2-epoxide,” Genbank Direct Submission. Accession Number U30169 (1998).

Affiliated with

Also associated with

Rating

Identification of congenital stationary night blindness in dogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification of congenital stationary night blindness in dogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of congenital stationary night blindness in dogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2919511